Zhuo Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhuo Li has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hexiang Bai
Key Laboratory of Environmental Medical Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
1 shared publication Jing Hao
Pediatric Intensive Care Unit, Children’s Hospital of Nanjing Medical University, Nanjing, China
1 shared publication- Kai Luo
Key Laboratory of Environmental Medical Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
1 shared publication Ming-Xing Fan
Pediatric Intensive Care Unit, Children’s Hospital of Nanjing Medical University, Nanjing, China
1 shared publicationQi-Rui Cheng
Pediatric Intensive Care Unit, Children’s Hospital of Nanjing Medical University, Nanjing, China
1 shared publication- Shanshan Ji
Key Laboratory of Environmental Medical Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
1 shared publication
Latest Publications
- Open Access
Quantitative Detection of Micro- and Nanoplastics (≥300 nm) in Human Urine Using Double-Shot Py-GC/MS with Internal Standard Calibration
The rapid increase in plastic production and consumption has intensified research into human exposure to micro- and nanoplastics (MNPs) and their health effects. This study quantitatively assessed MNP internal exposure levels in non-invasive human samples, focusing on the four most common types of MNPs (≥300 nm): polyethylene terephthalate (PET), polypropylene (PP), low-density polyethylene (LDPE), and polystyrene (PS). Urine samples from 18 volunteers (4 males, 14 females) were analyzed using pyrolysis–gas chromatography–mass spectrometry (Py-GC/MS) with P(E-13C2) as an internal standard. The study developed a straightforward yet effective analytical approach for quantifying MNPs in biological fluids. MNPs were detected in all urine samples, with concentrations ranging from 0.098 to 0.986 μg/mL and an average concentration of 0.268 ± 0.235 μg/mL. LDPE, 0.074 μg/mL (interquartile range: 0.030–0.243 μg/mL), was the most abundant polymer, accounting for 67.72% of the total MNPs, followed by PS at 21.17%, while PP and PET accounted for 7.06% and 4.05%, respectively. The results also suggest that drinking water type may serve as a distinct source of MNPs in urine. This study provides novel evidence on MNP (≥300 nm) internal exposure in humans and the influence of drinking habits, highlighting the application prospects of this method in assessing the potential health risks of MNPs.
Open AccessQuantitative Detection of Micro- and Nanoplastics (≥300 nm) in Human Urine Using Double-Shot Py-GC/MS with Internal Standard Calibration
The rapid increase in plastic production and consumption has intensified research into human exposure to micro- and nanoplastics (MNPs) and their health effects. This study quantitatively assessed MNP internal exposure levels in non-invasive human samples, focusing on the four most common types of MNPs (≥300 nm): polyethylene terephthalate (PET), polypropylene (PP), low-density polyethylene (LDPE), and polystyrene (PS). Urine samples from 18 volunteers (4 males, 14 females) were analyzed using pyrolysis–gas chromatography–mass spectrometry (Py-GC/MS) with P(E-13C2) as an internal standard. The study developed a straightforward yet effective analytical approach for quantifying MNPs in biological fluids. MNPs were detected in all urine samples, with concentrations ranging from 0.098 to 0.986 μg/mL and an average concentration of 0.268 ± 0.235 μg/mL. LDPE, 0.074 μg/mL (interquartile range: 0.030–0.243 μg/mL), was the most abundant polymer, accounting for 67.72% of the total MNPs, followed by PS at 21.17%, while PP and PET accounted for 7.06% and 4.05%, respectively. The results also suggest that drinking water type may serve as a distinct source of MNPs in urine. This study provides novel evidence on MNP (≥300 nm) internal exposure in humans and the influence of drinking habits, highlighting the application prospects of this method in assessing the potential health risks of MNPs.
- 22 November 2021
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 18 (1) , 37-42
Chest CT features of children infected by B.1.617.2 (Delta) variant of COVID-19
Background This study aimed to explore the imaging characteristics, diversity and changing trend in CT scans of pediatric patients infected with Delta-variant strain by studying imaging features of children infected with Delta and comparing the results to those of children with original COVID-19. Methods A retrospective, comparative analysis of initial chest CT manifestations between 63 pediatric patients infected with Delta variant in 2021 and 23 pediatric patients with COVID-19 in 2020 was conducted. Corresponding imaging features were analyzed. In addition, the changing trend in imaging features of COVID-19 Delta-variant cases were explored by evaluating the initial and follow-up CT scans. Results Among 63 children with Delta-variant COVID-19 in 2021, 34 (53.9%) showed positive chest CT presentation; and their CT score (1.10 ± 1.41) was significantly lower than that in 2020 (2.56 ± 3.5) (P = 0.0073). Lesion distribution: lung lesions of Delta cases appear mainly in the lower lungs on both sides. Most children had single lobe involvement (18 cases, 52.9%), 14 (41.2%) in the right lung alone, and 14 (41.2%) in both lungs. A majority of Delta cases displayed initially ground glass (23 cases, 67.6%) and nodular shadows (13 cases, 38.2%) in the first CT scan, with few extrapulmonary manifestations. The 34 children with abnormal chest CT for the first time have a total of 92 chest CT examinations. These children showed a statistically significant difference between the 0–3 day group and the 4–7 day group (P = 0.0392) and a significant difference between the 4–7 day group and the more than 8 days group (P = 0.0003). Conclusions The early manifestations of COVID-19 in children with abnormal imaging are mostly small subpleural nodular ground glass opacity. The changes on the Delta-variant COVID-19 chest CT were milder than the original strain. The lesions reached a peak on CT in 4–7 days and quickly improved and absorbed after a week. Dynamic CT re-examination can achieve a good prognosis.
- 22 November 2021
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 18 (1) , 37-42
Chest CT features of children infected by B.1.617.2 (Delta) variant of COVID-19
Background This study aimed to explore the imaging characteristics, diversity and changing trend in CT scans of pediatric patients infected with Delta-variant strain by studying imaging features of children infected with Delta and comparing the results to those of children with original COVID-19. Methods A retrospective, comparative analysis of initial chest CT manifestations between 63 pediatric patients infected with Delta variant in 2021 and 23 pediatric patients with COVID-19 in 2020 was conducted. Corresponding imaging features were analyzed. In addition, the changing trend in imaging features of COVID-19 Delta-variant cases were explored by evaluating the initial and follow-up CT scans. Results Among 63 children with Delta-variant COVID-19 in 2021, 34 (53.9%) showed positive chest CT presentation; and their CT score (1.10 ± 1.41) was significantly lower than that in 2020 (2.56 ± 3.5) (P = 0.0073). Lesion distribution: lung lesions of Delta cases appear mainly in the lower lungs on both sides. Most children had single lobe involvement (18 cases, 52.9%), 14 (41.2%) in the right lung alone, and 14 (41.2%) in both lungs. A majority of Delta cases displayed initially ground glass (23 cases, 67.6%) and nodular shadows (13 cases, 38.2%) in the first CT scan, with few extrapulmonary manifestations. The 34 children with abnormal chest CT for the first time have a total of 92 chest CT examinations. These children showed a statistically significant difference between the 0–3 day group and the 4–7 day group (P = 0.0392) and a significant difference between the 4–7 day group and the more than 8 days group (P = 0.0003). Conclusions The early manifestations of COVID-19 in children with abnormal imaging are mostly small subpleural nodular ground glass opacity. The changes on the Delta-variant COVID-19 chest CT were milder than the original strain. The lesions reached a peak on CT in 4–7 days and quickly improved and absorbed after a week. Dynamic CT re-examination can achieve a good prognosis.